New Delhi, Oct 17 (IANS) In a first, scientists at the Institute of Nano Science and Technology (INST), Mohali, an autonomous institute of the Department of Science and Technology (DST) have developed a unique way through the nose to deliver tuberculosis (TB) medicines directly to the brain.
TB that affects the brain is called Central Nervous System Tuberculosis (CNS-TB) and is one of the most dangerous forms of TB, often leading to severe complications or death.
The novel nose-to-brain (N2B) drug delivery utilizes the olfactory and trigeminal nerve pathways in the nasal cavity and effectively bypasses the challenging blood-brain barrier (BBB).
While traditional treatments involve high doses of oral anti-TB drugs, they often fail to achieve effective concentrations in the cerebrospinal fluid as the BBB limits the medicines from entering the brain.
To counter this, the INST team used nanoparticles made of a natural material called chitosan, which bypassed the BBB and delivered TB medicines directly to the brain via the nose. Chitosan is a biocompatible and biodegradable material.
The chitosan nano-aggregates could hold TB drugs like isoniazid (INH) and rifampicin (RIF). Importantly, chitosan — known for its mucoadhesive properties — sticks to the nasal mucosa, which helps the nano-aggregates stay in place and prolongs the time they can release the drug, enhancing its therapeutic effectiveness.
“In mice infected with TB, the nasal delivery of these nano-aggregates reduced the number of bacteria in the brain by nearly 1,000 times more than in untreated mice,” said the team in the paper, published in the journal Nanoscale (Royal Society of Chemistry).
The new treatment method also helps reduce the inflammation caused by the infection, an advance that has the potential to greatly improve treatment for people suffering from brain TB and could help in faster recovery.
According to scientists, the novel method could be applied to treat other brain infections, neurodegenerative diseases like Alzheimer’s and Parkinson’s, brain tumors, and epilepsy by enabling efficient drug delivery to the brain.
-IANS
rvt/
Go to Source
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event we will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website. .
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source,
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
